| Previous close | 15.00 |
| Open | 15.00 |
| Bid | 15.16 x 84100 |
| Ask | 15.50 x 12400 |
| Day's range | 15.00 - 15.60 |
| 52-week range | 12.96 - 21.45 |
| Volume | |
| Avg. volume | 142,645 |
| Market cap | 771.097M |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | 27.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.05 (0.32%) |
| Ex-dividend date | 05 Sept 2023 |
| 1y target est | N/A |
- Simply Wall St.
Is Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Clinuvel Pharmaceuticals' (ASX:CUV) stock is up by a considerable 8.7% over the past month. Since the market usually...
- Simply Wall St.
Clinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 50% loss from investing in the stock three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Clinuvel Pharmaceuticals...
- Simply Wall St.
Clinuvel Pharmaceuticals Limited's (ASX:CUV) largest shareholders are retail investors with 59% ownership, institutions own 20%
Key Insights Clinuvel Pharmaceuticals' significant retail investors ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.